In NSCLC patients, exosomal PD-L1 inhibited CD8+ T cell activity dose-dependently, induced CD8+ T cell apoptosis, and decreased IL-2 and IFN-γ production [31]. This evidence concerns the gene IL2 and non-small cell lung carcinoma.